Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Cancer Genome Sequencing Market 2016: Industry Segmentation, Parameters and Prospects 2016 to 2022

Friday, October 7, 2016 6:34
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Latest industry research report on: Global Cancer Genome Sequencing Market 2016: Industry Research, Size, Shares, Key Trends, Demand, Growth to 2022

Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells. It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations. This technique has proved to be a breakthrough in the fight against cancer as it assists in individualization of treatment.

Development of new methods and exponential decrease in genome sequencing cost are fueling the market growth. Global cancer genome sequencing market is expected grow with a healthy CAGR due to technological advances and entry of new market players. Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson, LI-COR Biosciences (Lincoln, NE), Abbott Laboratories, Beckman Coulter (Fullerton, CA), Bayer Corporation, Hamilton Thorne Biosciences, Integrated DNA Technologies, Microchip Biotechnologies, Myriad Genetics, Commonwealth Biotechnologies, ZS Genetics, and Pacific Biosciences are some of the key players of this market.

Get Free Sample Report Of Cancer Genome Sequencing Market :

The global cancer genome sequencing market is segmented on the basis of technology and geography. The currently technologies used include second generation and third generation platforms. Second generation technology platforms include SOLiD sequencing (by ABI), Pyro-sequencing (by Roche) and Bridge amplification sequencing technology (by Illumina). Third generation technology platform includes Single Molecule Real Time (SMRT) sequencing (by Pacific Biosciences), Ion semiconductor sequencing, Nanopore sequencing (by Oxford) and fluorescent resonant energy transfer (FRET) sequencing (by VisiGen biotechnologies).

Geographically, the global cancer genome sequencing market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global cancer genome sequencing market due to availability of advanced technologies and a skilled workforce. This market is driven by whole genome sequencing coupled with bioinformatics based sequencing technologies which provide personalized treatments for cancer.

Have Any Query? Ask Our Expert @


This report offers the following benefits in particular:

  • Pin-point analysis of geographic segments helps to identify opportunities for growth within the global cancer genome sequencing market
  • Porter’s Five Forces analysis examines the competitive structure of the global cancer genome sequencing market and would assist market strategists in their decision-making process.
  • In-depth coverage of the global cancer genome sequencing market including drivers, restraints and opportunities would help professionals to better understand market behavior
  • Detailed study of the strategies of key leaders, partnerships and acquisitions in the global cancer genome sequencing market would be informative for professionals in the corporate sector
  • KEY MARKET SEGMENTS The global cancer genome sequencing market is segmented into two broad categories: technology and geography.


  • Second Generation Technology Platforms
  • SOLiD sequencing (by ABI)
  • Pyro-sequencing (by Roche)
  • Bridge amplification sequencing technology (by Illumina)
  • Third Generation Technology Platforms
  • Single Molecule Real Time (SMRT) sequencing (by Pacific Biosciences)
  • Ion semiconductor sequencing.
  • Nanopore sequencing (by Oxford)
  • fluorescent resonant energy transfer (FRET) sequencing (by VisiGen biotechnologies)


  • North America
  • Europe
  • Asia-Pacific

About Custom Market Insights:

Market Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.

Custom Market Insights is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive.

What makes us different from our competitors?

Compared to our competitors, our offerings include, but are not limited to market research services on latest industry trends, customized study at reasonable price, and database bigger than our competitors and provide more relevant results to fit your needs.

Contact Us

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.